{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:18:39Z","timestamp":1792523919401,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00439735"],"award-info":[{"award-number":["RS-2024-00439735"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-NR077244"],"award-info":[{"award-number":["RS-2023-NR077244"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00352668"],"award-info":[{"award-number":["RS-2024-00352668"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004358","name":"Samsung","doi-asserted-by":"publisher","award":["SSTF-BA1902-05"],"award-info":[{"award-number":["SSTF-BA1902-05"]}],"id":[{"id":"10.13039\/100004358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014364","name":"Samsung Science and Technology Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014364","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-00302794"],"award-info":[{"award-number":["RS-2023-00302794"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02852-9","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:02:08Z","timestamp":1787702528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma"],"prefix":"10.1038","volume":"11","author":[{"given":"In","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Hoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Hyeon","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwoo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongwoo","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5193-4868","authenticated-orcid":false,"given":"Inju","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7807-7389","authenticated-orcid":false,"given":"Minji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-1597","authenticated-orcid":false,"given":"Stephen","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Byum","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-1510","authenticated-orcid":false,"given":"Heung Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2852_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco, F., Jaccard, A., Romero, P., Yu, Y. R. & Ho, P. C. Metabolic and epigenetic regulation of T-cell exhaustion. Nat. Metab. 2, 1001\u20131012 (2020).","journal-title":"Nat. Metab."},{"key":"2852_CR2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","volume":"20","author":"DV Sawant","year":"2019","unstructured":"Sawant, D. V. et al. Adaptive plasticity of IL-10+ and IL-35+ T(reg) cells cooperatively promotes tumor T cell exhaustion. Nat. Immunol. 20, 724\u2013735 (2019).","journal-title":"Nat. Immunol."},{"key":"2852_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28523-1","volume":"13","author":"VM Ravi","year":"2022","unstructured":"Ravi, V. M. et al. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat. Commun. 13, 925 (2022).","journal-title":"Nat. Commun."},{"key":"2852_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping, N. E. et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat. Immunol. 22, 205\u2013215 (2021).","journal-title":"Nat. Immunol."},{"key":"2852_CR5","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","volume":"25","author":"RM Peralta","year":"2024","unstructured":"Peralta, R. M. et al. Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat. Immunol. 25, 2297\u20132307 (2024).","journal-title":"Nat. Immunol."},{"key":"2852_CR6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S1470-2045(21)00097-8","volume":"22","author":"I Pires da Silva","year":"2021","unstructured":"Pires da Silva, I. et al. Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study. Lancet Oncol. 22, 836\u2013847 (2021).","journal-title":"Lancet Oncol."},{"key":"2852_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/1759-7714.13867","volume":"12","author":"ABC Brito","year":"2021","unstructured":"Brito, A. B. C., Camandaroba, M. P. G. & de Lima, V. C. C. Anti-PD1 versus anti-PD-L1 immunotherapy in first-line therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis. Thorac. Cancer 12, 1058\u20131066 (2021).","journal-title":"Thorac. Cancer"},{"key":"2852_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.trecan.2022.12.008","volume":"9","author":"MB Watowich","year":"2023","unstructured":"Watowich, M. B., Gilbert, M. R. & Larion, M. T cell exhaustion in malignant gliomas. Trends Cancer 9, 270\u2013292 (2023).","journal-title":"Trends Cancer"},{"key":"2852_CR9","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-23-0913","volume":"14","author":"AZ Wang","year":"2024","unstructured":"Wang, A. Z. et al. Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population. Cancer Discov. 14, 1106\u20131131 (2024).","journal-title":"Cancer Discov."},{"key":"2852_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41577-021-00563-6","volume":"22","author":"X Zhao","year":"2022","unstructured":"Zhao, X., Shan, Q. & Xue, H. H. TCF1 in T cell immunity: a broadened frontier. Nat. Rev. Immunol. 22, 147\u2013157 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2852_CR11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","volume":"21","author":"DT Utzschneider","year":"2020","unstructured":"Utzschneider, D. T. et al. Early precursor T cells establish and propagate T cell exhaustion in chronic infection. Nat. Immunol. 21, 1256\u20131266 (2020).","journal-title":"Nat. Immunol."},{"key":"2852_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1182\/blood.2020009309","volume":"138","author":"W Zheng","year":"2021","unstructured":"Zheng, W. et al. Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL. Blood 138, 122\u2013135 (2021).","journal-title":"Blood"},{"key":"2852_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"ZY Chen","year":"2019","unstructured":"Chen, Z. Y. et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity 51, 840\u2013855.e5 (2019).","journal-title":"Immunity"},{"key":"2852_CR14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41423-020-0436-5","volume":"18","author":"Q Shan","year":"2021","unstructured":"Shan, Q. et al. Ectopic Tcf1 expression instills a stem-like program in exhausted CD8+ T cells to enhance viral and tumor immunity. Cell. Mol. Immunol. 18, 1262\u20131277 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"2852_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1432-0436.2008.00272.x","volume":"76","author":"R Wang","year":"2008","unstructured":"Wang, R. et al. Retinoic acid maintains self-renewal of murine embryonic stem cells via a feedback mechanism. Differentiation 76, 931\u2013945 (2008).","journal-title":"Differentiation"},{"key":"2852_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1074\/jbc.M109.053926","volume":"285","author":"R Yasuhara","year":"2010","unstructured":"Yasuhara, R. et al. Wnt\/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover. J. Biol. Chem. 285, 317\u2013327 (2010).","journal-title":"J. Biol. Chem."},{"key":"2852_CR17","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.stemcr.2018.04.024","volume":"10","author":"S Mishra","year":"2018","unstructured":"Mishra, S., Kelly, K. K., Rumian, N. L. & Siegenthaler, J. A. Retinoic acid is required for neural stem and progenitor cell proliferation in the adult hippocampus. Stem Cell Rep. 10, 1705\u20131720 (2018).","journal-title":"Stem Cell Rep."},{"key":"2852_CR18","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","volume":"181","author":"S Xiao","year":"2008","unstructured":"Xiao, S. et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181, 2277\u20132284 (2008).","journal-title":"J. Immunol."},{"key":"2852_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.immuni.2015.02.003","volume":"42","author":"CC Brown","year":"2015","unstructured":"Brown, C. C. et al. Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program. Immunity 42, 499\u2013511 (2015).","journal-title":"Immunity"},{"key":"2852_CR20","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1093\/jn\/132.12.3736","volume":"132","author":"KA Hoag","year":"2002","unstructured":"Hoag, K. A., Nashold, F. E., Goverman, J. & Hayes, C. E. Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J. Nutr. 132, 3736\u20133739 (2002).","journal-title":"J. Nutr."},{"key":"2852_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.1440-1711.2000.00889.x","volume":"78","author":"SR Clarke","year":"2000","unstructured":"Clarke, S. R. et al. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol. Cell. Biol. 78, 110\u2013117 (2000).","journal-title":"Immunol. Cell. Biol."},{"key":"2852_CR22","doi-asserted-by":"publisher","first-page":"e009449","DOI":"10.1136\/jitc-2024-009449","volume":"12","author":"KB Ku","year":"2024","unstructured":"Ku, K. B. et al. Inhibitory Fcgamma receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastoma. J. Immunother. Cancer 12, e009449 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2852_CR23","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1182\/bloodadvances.2020003080","volume":"5","author":"M Roussel","year":"2021","unstructured":"Roussel, M. et al. Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade. Blood Adv. 5, 1816\u20131829 (2021).","journal-title":"Blood Adv."},{"key":"2852_CR24","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1038\/s41588-023-01554-0","volume":"55","author":"SR McCutcheon","year":"2023","unstructured":"McCutcheon, S. R. et al. Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens. Nat. Genet. 55, 2211\u20132223 (2023).","journal-title":"Nat. Genet."},{"key":"2852_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1158\/0008-5472.CAN-16-2684","volume":"78","author":"FP Canale","year":"2018","unstructured":"Canale, F. P. et al. CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells. Cancer Res 78, 115\u2013128 (2018).","journal-title":"Cancer Res"},{"key":"2852_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ni889","volume":"4","author":"EJ Wherry","year":"2003","unstructured":"Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225\u2013234 (2003).","journal-title":"Nat. Immunol."},{"key":"2852_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adt3537","volume":"10","author":"A Ray","year":"2025","unstructured":"Ray, A. et al. Multimodal delineation of a layer of effector function among exhausted CD8 T cells in tumors. Sci. Immunol. 10, eadt3537 (2025).","journal-title":"Sci. Immunol."},{"key":"2852_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","volume":"58","author":"J Waibl Polania","year":"2025","unstructured":"Waibl Polania, J. et al. Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity 58, 232\u2013246.e6 (2025).","journal-title":"Immunity"},{"key":"2852_CR29","doi-asserted-by":"publisher","first-page":"e1648170","DOI":"10.1080\/2162402X.2019.1648170","volume":"8","author":"R De Groot","year":"2019","unstructured":"De Groot, R. et al. Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile. Oncoimmunology 8, e1648170 (2019).","journal-title":"Oncoimmunology"},{"key":"2852_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/cr.2011.127","volume":"22","author":"J Gwak","year":"2012","unstructured":"Gwak, J. et al. Small molecule-based disruption of the Axin\/beta-catenin protein complex regulates mesenchymal stem cell differentiation. Cell Res 22, 237\u2013247 (2012).","journal-title":"Cell Res"},{"key":"2852_CR31","doi-asserted-by":"publisher","first-page":"101377","DOI":"10.1016\/j.xcrm.2023.101377","volume":"5","author":"J Sprooten","year":"2024","unstructured":"Sprooten, J. et al. Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells. Cell Rep. Med. 5, 101377 (2024).","journal-title":"Cell Rep. Med."},{"key":"2852_CR32","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/carcin\/bgaa063","volume":"41","author":"M Croce","year":"2020","unstructured":"Croce, M. et al. Increased Arginase1 expression in tumor microenvironment promotes mammary carcinogenesis via multiple mechanisms. Carcinogenesis 41, 1695\u20131702 (2020).","journal-title":"Carcinogenesis"},{"key":"2852_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1956143","volume":"10","author":"A Sosnowska","year":"2021","unstructured":"Sosnowska, A. et al. Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma. Oncoimmunology 10, 1956143 (2021).","journal-title":"Oncoimmunology"},{"key":"2852_CR34","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3945\/ajcn.116.149039","volume":"105","author":"JK Hodges","year":"2017","unstructured":"Hodges, J. K., Tan, L., Green, M. H. & Ross, A. C. Vitamin A supplementation redirects the flow of retinyl esters from peripheral to central organs of neonatal rats raised under vitamin A-marginal conditions. Am. J. Clin. Nutr. 105, 1110\u20131121 (2017).","journal-title":"Am. J. Clin. Nutr."},{"key":"2852_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.it.2016.11.005","volume":"38","author":"R Mirzaei","year":"2017","unstructured":"Mirzaei, R., Sarkar, S. & Yong, V. W. T cell exhaustion in glioblastoma: intricacies of immune checkpoints. Trends Immunol. 38, 104\u2013115 (2017).","journal-title":"Trends Immunol."},{"key":"2852_CR36","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","volume":"6","author":"DA Reardon","year":"2020","unstructured":"Reardon, D. A. et al. Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial. JAMA Oncol. 6, 1003\u20131010 (2020).","journal-title":"JAMA Oncol."},{"key":"2852_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"JH Lee","year":"2018","unstructured":"Lee, J. H. et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 560, 243\u2013247 (2018).","journal-title":"Nature"},{"key":"2852_CR38","doi-asserted-by":"publisher","first-page":"101607","DOI":"10.1016\/j.xpro.2022.101607","volume":"3","author":"JH Park","year":"2022","unstructured":"Park, J. H. et al. Protocol to analyze antitumor immunity of orthotopic injection and spontaneous murine high-grade glioma models using flow cytometry and single-cell RNA sequencing. STAR Protoc. 3, 101607 (2022).","journal-title":"STAR Protoc."},{"key":"2852_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03954-z","volume":"24","author":"S Rogers","year":"2024","unstructured":"Rogers, S. et al. Re-irradiation for recurrent glioblastoma: a pattern of care analysis. BMC Neurol. 24, 462 (2024).","journal-title":"BMC Neurol."},{"key":"2852_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/neuonc\/nos273","volume":"15","author":"M Weller","year":"2013","unstructured":"Weller, M., Cloughesy, T., Perry, J. R. & Wick, W. Standards of care for treatment of recurrent glioblastoma\u2013are we there yet? Neuro Oncol. 15, 4\u201327 (2013).","journal-title":"Neuro Oncol."},{"key":"2852_CR41","first-page":"1","volume":"16","author":"O Sacko","year":"2021","unstructured":"Sacko, O. et al. The impact of surgery on the survival of patients with recurrent glioblastoma. Asian J. Neurosurg. 16, 1\u20137 (2021).","journal-title":"Asian J. Neurosurg."},{"key":"2852_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00701-025-06633-1","volume":"167","author":"S Oki","year":"2025","unstructured":"Oki, S. et al. Recurrence patterns and clinical outcomes in adult cerebellar glioblastoma. Acta Neurochir. (Wien.) 167, 217 (2025).","journal-title":"Acta Neurochir. (Wien.)"},{"key":"2852_CR43","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2176\/nmc.52.577","volume":"52","author":"Y Konishi","year":"2012","unstructured":"Konishi, Y., Muragaki, Y., Iseki, H., Mitsuhashi, N. & Okada, Y. Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant management: retrospective analysis of 43 cases. Neurol. Med. Chir. (Tokyo) 52, 577\u2013586 (2012).","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"2852_CR44","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","volume":"24","author":"M Lim","year":"2022","unstructured":"Lim, M. et al. Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter. Neuro Oncol. 24, 1935\u20131949 (2022).","journal-title":"Neuro Oncol."},{"key":"2852_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/neuonc\/noac099","volume":"25","author":"A Omuro","year":"2023","unstructured":"Omuro, A. et al. Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial. Neuro Oncol. 25, 123\u2013134 (2023).","journal-title":"Neuro Oncol."},{"key":"2852_CR46","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41591-018-0339-5","volume":"25","author":"KA Schalper","year":"2019","unstructured":"Schalper, K. A. et al. Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. Nat. Med. 25, 470\u2013476 (2019).","journal-title":"Nat. Med."},{"key":"2852_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y Mei","year":"2023","unstructured":"Mei, Y. et al. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat. Cancer 4, 1273\u20131291 (2023).","journal-title":"Nat. Cancer"},{"key":"2852_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"2852_CR49","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2852_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients. Genom. Proteom. Bioinforma. 19, 1\u201312 (2021).","journal-title":"Genom. Proteom. Bioinforma."},{"key":"2852_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140508","volume":"132","author":"BY Sung","year":"2022","unstructured":"Sung, B. Y. et al. Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1. J. Clin. Invest. 132, e140508 (2022).","journal-title":"J. Clin. Invest."},{"key":"2852_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ccell.2025.03.007","volume":"43","author":"I Mosialou","year":"2025","unstructured":"Mosialou, I. et al. A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies. Cancer Cell 43, 1007\u20131024.e13 (2025).","journal-title":"Cancer Cell"},{"key":"2852_CR53","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.immuni.2023.07.015","volume":"56","author":"D Chen","year":"2023","unstructured":"Chen, D. et al. CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma. Immunity 56, 2086\u20132104.e8 (2023).","journal-title":"Immunity"},{"key":"2852_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55455-9","volume":"16","author":"JM Grimes","year":"2025","unstructured":"Grimes, J. M. et al. Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma. Nat. Commun. 16, 1095 (2025).","journal-title":"Nat. Commun."},{"key":"2852_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55360","volume":"9","author":"X Zhao","year":"2020","unstructured":"Zhao, X. et al. beta-catenin and gamma-catenin are dispensable for T lymphocytes and AML leukemic stem cells. Elife 9, e55360 (2020).","journal-title":"Elife"},{"key":"2852_CR56","first-page":"311","volume":"34","author":"E Quartin","year":"2024","unstructured":"Quartin, E. et al. Nanoparticle-encapsulated retinoic acid for the modulation of bone marrow hematopoietic stem cell niche. Bioact. Mater. 34, 311\u2013325 (2024).","journal-title":"Bioact. Mater."},{"key":"2852_CR57","doi-asserted-by":"publisher","first-page":"19519","DOI":"10.1074\/jbc.M114.556555","volume":"289","author":"AM Urvalek","year":"2014","unstructured":"Urvalek, A. M. & Gudas, L. J. Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells. J. Biol. Chem. 289, 19519\u201319530 (2014).","journal-title":"J. Biol. Chem."},{"key":"2852_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ccell.2022.12.007","volume":"41","author":"M Kilian","year":"2023","unstructured":"Kilian, M. et al. MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors. Cancer Cell 41, 235\u2013251.e9 (2023).","journal-title":"Cancer Cell"},{"key":"2852_CR59","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1053\/j.gastro.2005.07.025","volume":"129","author":"S Sato","year":"2005","unstructured":"Sato, S. et al. Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology 129, 1225\u20131236 (2005).","journal-title":"Gastroenterology"},{"key":"2852_CR60","doi-asserted-by":"publisher","first-page":"10560","DOI":"10.1158\/0008-5472.CAN-06-2526","volume":"66","author":"HK Lee","year":"2006","unstructured":"Lee, H. K., Choi, Y. S., Park, Y. A. & Jeong, S. Modulation of oncogenic transcription and alternative splicing by beta-catenin and an RNA aptamer in colon cancer cells. Cancer Res. 66, 10560\u201310566 (2006).","journal-title":"Cancer Res."},{"key":"2852_CR61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jneumeth.2017.04.019","volume":"284","author":"J Bianco","year":"2017","unstructured":"Bianco, J. et al. Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice. J. Neurosci. Methods 284, 96\u2013102 (2017).","journal-title":"J. Neurosci. Methods"},{"key":"2852_CR62","doi-asserted-by":"publisher","first-page":"103304","DOI":"10.1016\/j.xpro.2024.103304","volume":"5","author":"R Pineau","year":"2024","unstructured":"Pineau, R. et al. Protocol to generate two distinct standard-of-care murine glioblastoma models for evaluating novel combination therapies. STAR Protoc. 5, 103304 (2024).","journal-title":"STAR Protoc."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02852-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02852-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02852-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:02:10Z","timestamp":1787702530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02852-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2852"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02852-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.-B.C. is a founder, shareholder, and employee of a company specializing in imaging services; this research was conducted independently and is not affiliated with the company. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"348"}}